Corticobasal degeneration

Seminars in Neurology

Volumn 34, Issue 2, 2014, Pages 160-173

  Grijalvo Perez, Ana M ^a   Litvan, Irene ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

atypical parkinsonian syndromes; corticobasal degeneration; corticobasal syndrome; frontotemporal dementia; neurodegeneration; nonfluent progressive aphasia; progressive supranuclear palsy; tauopathy

Indexed keywords

BIOLOGICAL MARKER; LEVODOPA; TAU PROTEIN;

AGE DISTRIBUTION; AGNOSIA; ALIEN HAND SYNDROME; ALZHEIMER DISEASE; APHASIA; APRAXIA; AUTOPSY; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DYSARTHRIA; DYSPHAGIA; DYSTONIA; EVOKED RESPONSE; EYE MOVEMENT DISORDER; GAIT DISORDER; GENETICS; HUMAN; IDEOMOTOR APRAXIA; INCIDENCE; LANGUAGE DISABILITY; MOTONEURON; MYOCLONUS; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RIGIDITY; RISK FACTOR; SEX RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TAUOPATHY; TREMOR; VISUAL DEPRIVATION; BRAIN CORTEX; NEURODEGENERATIVE DISEASES; PATHOLOGY;

CEREBRAL CORTEX; HUMANS; INCIDENCE; NEURODEGENERATIVE DISEASES; PREVALENCE; RISK FACTORS;

EID: 84903316944     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0034-1381734     Document Type: Review

References (118)

1. Armstrong M. J., Litvan I., Lang A. E., et al. Criteria for the diagnosis of corticobasal degeneration. Neurology: 2013; 80 5 496 503
2. Dickson D. W., Bergeron C., Chin S. S., et al. Office of Rare Diseases of the National Institutes of Health. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol: 2002; 61 11 935 946
3. Kouri N., Whitwell J. L., Josephs K. A., Rademakers R., Dickson D. W. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol: 2011; 7 5 263 272
4. Dickson D. H., Hauw J-J, Agid Y., Litvan I. Progressive supranuclear palsy and corticobasal degeneration. In Dickson D. W., Weller R. O., eds. Neurodegeneration. 2nd ed. Hoboken, NJ Wiley/Blackwell: 2011
5. Kouri N., Murray M. E., Hassan A., et al. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain: 2011; 134 Pt 11 3264 3275
6. Dickson D. W. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol: 1999; 246 02 II6 II15
7. Boeve B. F. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci: 2011; 45 3 350 353
8. Rebeiz J. J., Kolodny E. H., Richardson E. P. Jr. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc: 1967; 92 23 26
9. Rebeiz J. J., Kolodny E. H., Richardson E. P. Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol: 1968; 18 1 20 33
10. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1985. A 66-year-old man with progressive neurologic deterioration. N Engl J Med: 1985; 313 12 739 748
11. Gibb W. R., Luthert P. J., Marsden C. D. Corticobasal degeneration. Brain: 1989; 112 Pt 5 1171 1192
12. Chand P., Grafman J., Dickson D., Ishizawa K., Litvan I. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord: 2006; 21 11 2018 2022
13. Lang A. E., Bergeron C., Pollanen M. S., Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology: 1994; 44 8 1436 1440
14. Boeve B. F., Lang A. E., Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol: 2003; 54 05 S15 S19
15. Litvan I. Progressive supranuclear palsy and corticobasal degeneration. Baillieres Clin Neurol: 1997; 6 1 167 185
16. Togasaki D. M., Tanner C. M. Epidemiologic aspects. Adv Neurol: 2000; 82 53 59
17. Stacy M., Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin: 1992; 10 2 341 359
18. Winter Y., Bezdolnyy Y., Katunina E., et al. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study. Mov Disord: 2010; 25 3 349 356
19. Osaki Y., Morita Y., Kuwahara T., Miyano I., Doi Y. Prevalence of Parkinson's disease and atypical parkinsonian syndromes in a rural Japanese district. Acta Neurol Scand: 2011; 124 3 182 187
20. Wenning G. K., Litvan I., Jankovic J., et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry: 1998; 64 2 184 189
21. Rinne J. O., Lee M. S., Thompson P. D., Marsden C. D. Corticobasal degeneration. A clinical study of 36 cases. Brain: 1994; 117 Pt 5 1183 1196
22. DePold Hohler A., Ransom B. R., Chun M. R., Tröster A. I., Samii A. The youngest reported case of corticobasal degeneration. Parkinsonism Relat Disord: 2003; 10 1 47 50
23. Litvan I., Grimes D. A., Lang A. E. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol: 2000; 82 183 196
24. Kompoliti K., Goetz C. G., Boeve B. F., et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol: 1998; 55 7 957 961
25. Watts R. MS, Richardson E. P. Corticobasal ganglionic degenereration. Oxford Butterworth-Heinemann: 1994
26. Murray R., Neumann M., Forman M. S., et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology: 2007; 68 16 1274 1283
27. Smith T. W., Lippa C. F., de Girolami U. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia. Clin Neuropathol: 1992; 11 1 28 35
28. Lewis J., McGowan E., Rockwood J., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet: 2000; 25 4 402 405
29. Ishizawa K., Dickson D. W. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol: 2001; 60 6 647 657
30. Bhaskar K., Konerth M., Kokiko-Cochran O. N., Cardona A., Ransohoff R. M., Lamb B. T. Regulation of tau pathology by the microglial fractalkine receptor. Neuron: 2010; 68 1 19 31
31. Ittner L. M., Ke Y. D., Delerue F., et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell: 2010; 142 3 387 397
32. Hoover B. R., Reed M. N., Su J., et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron: 2010; 68 6 1067 1081
33. Baker M., Litvan I., Houlden H., et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet: 1999; 8 4 711 715
34. Houlden H., Baker M., Morris H. R., et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology: 2001; 56 12 1702 1706
35. Bugiani O., Murrell J. R., Giaccone G., et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol: 1999; 58 6 667 677
36. Spillantini M. G., Yoshida H., Rizzini C., et al. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol: 2000; 48 6 939 943
37. Höglinger G. U., Melhem N. M., Dickson D. W., et al. PSP Genetics Study Group. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet: 2011; 43 7 699 705
38. Unterberger U., Höftberger R., Gelpi E., Flicker H., Budka H., Voigtländer T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol: 2006; 65 4 348 357
39. Wenning G. K., Litvan I., Tolosa E. Milestones in atypical and secondary parkinsonisms. Mov Disord: 2011; 26 6 1083 1095
40. Spina S., Murrell J. R., Huey E. D., et al. Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol: 2007; 66 10 892 900
41. Masellis M., Momeni P., Meschino W., et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain: 2006; 129 Pt 11 3115 3123
42. Fekete R., Bainbridge M., Baizabal-Carvallo J. F., et al. Exome sequencing in familial corticobasal degeneration. Parkinsonism Relat Disord: 2013; 19 11 1049 1052
43. Higgins J. J., Litvan I., Nee L. E., Loveless J. M. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration. Neurology: 1999; 52 2 404 406
44. Witman G. B., Cleveland D. W., Weingarten M. D., Kirschner M. W. Tubulin requires tau for growth onto microtubule initiating sites. Proc Natl Acad Sci U S A: 1976; 73 11 4070 4074
45. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y. C., Zaidi M. S., Wisniewski H. M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem: 1986; 261 13 6084 6089
46. Fahn S. JJ, Hallett M. Principles and Practice of Movement Disorders. 2nd ed. Amsterdam Elsevier: 2011
47. Reich S. G., Grill S. E. Corticobasal degeneration. Curr Treat Options Neurol: 2009; 11 3 179 185
48. Kumar R. BC, Pollanen M., Lang A. E. Corticobasal Degeneration. 3rd ed. Baltimore Lippincott Williams & Wilkins
49. Stover N. P., Watts R. L. Corticobasal degeneration. Semin Neurol: 2001; 21 1 49 58
50. Constantinescu R., Richard I., Kurlan R. Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Mov Disord: 2007; 22 15 2141 2148, quiz 2295
51. Frucht S., Fahn S., Chin S., Dhawan V., Eidelberg D. Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration. Mov Disord: 2000; 15 2 340 343
52. Hassan A., Whitwell J. L., Boeve B. F., et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord: 2010; 16 3 208 214
53. Müller J., Seppi K., Stefanova N., Poewe W., Litvan I., Wenning G. K. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord: 2002; 17 5 1041 1045
54. Factor S. A., Higgins D. S., Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology: 2006; 66 3 411 414
55. Lee S. E., Rabinovici G. D., Mayo M. C., et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol: 2011; 70 2 327 340
56. Stamelou M., Alonso-Canovas A., Bhatia K. P. Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases. Mov Disord: 2012; 27 6 696 702
57. Vanek Z. F., Jankovic J. Dystonia in corticobasal degeneration. Adv Neurol: 2000; 82 61 67
58. Godeiro-Junior C., Felício A. C., Barsottini O. G., et al. Clinical features of dystonia in atypical parkinsonism. Arq Neuropsiquiatr: 2008; 66 4 800 804
59. Riley D. E., Lang A. E., Lewis A., et al. Cortical-basal ganglionic degeneration. Neurology: 1990; 40 8 1203 1212
60. Thompson P. D., Day B. L., Rothwell J. C., Brown P., Britton T. C., Marsden C. D. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain: 1994; 117 Pt 5 1197 1207
61. Ling H., O'Sullivan S. S., Holton J. L., et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain: 2010; 133 Pt 7 2045 2057
62. Chen R., Ashby P., Lang A. E. Stimulus-sensitive myoclonus in akinetic-rigid syndromes. Brain: 1992; 115 Pt 6 1875 1888
63. Thompson P. D., Shibasaki H. Myoclonus in corticobasal degeneration and other neurodegenerations. Adv Neurol: 2000; 82 69 81
64. Müller J., Wenning G. K., Verny M., et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol: 2001; 58 2 259 264
65. Rivaud-Péchoux S., Vidailhet M., Gallouedec G., Litvan I., Gaymard B., Pierrot-Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology: 2000; 54 5 1029 1032
66. Vidailhet M., Rivaud-Péchoux S. Eye movement disorders in corticobasal degeneration. Adv Neurol: 2000; 82 161 167
67. Boxer A. L., Garbutt S., Seeley W. W., et al. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease. Arch Neurol: 2012; 69 4 509 517
68. Vidailhet M., Rivaud S., Gouider-Khouja N., et al. Eye movements in parkinsonian syndromes. Ann Neurol: 1994; 35 4 420 426
69. Heuer H. W., Mirsky J. B., Kong E. L., et al. Antisaccade task reflects cortical involvement in mild cognitive impairment. Neurology: 2013; 81 14 1235 1243
70. Rivaud-Péchoux S., Vidailhet M., Brandel J. P., Gaymard B. Mixing pro- and antisaccades in patients with parkinsonian syndromes. Brain: 2007; 130 Pt 1 256 264
71. Lang A. ERD, Bergeron C. Cortical-Basal Ganglionic Degeneration. Philadelphia WB Saunders: 1994
72. Bak T. H., Hodges J. R. Corticobasal degeneration: clinical aspects. Handb Clin Neurol: 2008; 89 509 521
73. Leiguarda R., Merello M., Balej J. Apraxia in corticobasal degeneration. Adv Neurol: 2000; 82 103 121
74. Leiguarda R., Lees A. J., Merello M., Starkstein S., Marsden C. D. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry: 1994; 57 4 455 459
75. Zadikoff C., Lang A. E. Apraxia in movement disorders. Brain: 2005; 128 Pt 7 1480 1497
76. Lang A. E. Cortical basal ganglionic degeneration presenting with progressive loss of speech output and orofacial dyspraxia. J Neurol Neurosurg Psychiatry: 1992; 55 11 1101
77. Huey E. D., Pardini M., Cavanagh A., et al. Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. Arch Neurol: 2009; 66 10 1274 1280
78. Pharr V., Uttl B., Stark M., Litvan I., Fantie B., Grafman J. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology: 2001; 56 7 957 963
79. Black S. E. Aphasia in corticobasal degeneration. Adv Neurol: 2000; 82 123 133
80. Grimes D. A., Lang A. E., Bergeron C. B. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology: 1999; 53 9 1969 1974
81. Frattali C. M., Grafman J., Patronas N., Makhlouf F., Litvan I. Language disturbances in corticobasal degeneration. Neurology: 2000; 54 4 990 992
82. Josephs K. A., Duffy J. R., Strand E. A., et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain: 2006; 129 Pt 6 1385 1398
83. Biran I., Chatterjee A. Alien hand syndrome. Arch Neurol: 2004; 61 2 292 294
84. Carrilho P. E., Caramelli P., Cardoso F., Barbosa E. R., Buchpiguel C. A., Nitrini R. Involuntary hand levitation associated with parietal damage: another alien hand syndrome. Arq Neuropsiquiatr: 2001; 59 (3-A): 521 525
85. Brainin M., Seiser A., Matz K. The mirror world of motor inhibition: the alien hand syndrome in chronic stroke. J Neurol Neurosurg Psychiatry: 2008; 79 3 246 252
86. Fitzgerald D. B., Drago V., Jeong Y., Chang Y. L., White K. D., Heilman K. M. Asymmetrical alien hands in corticobasal degeneration. Mov Disord: 2007; 22 4 581 584
87. Denny-Brown D. The nature of apraxia. J Nerv Ment Dis: 1958; 126 1 9 32
88. Rajagopal R., Bateman R., Van Stavern G. P. Visual involvement in corticobasal syndrome. J Neuroophthalmol: 2012; 32 4 338 340
89. Tang-Wai D. F., Josephs K. A., Boeve B. F., Dickson D. W., Parisi J. E., Petersen R. C. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology: 2003; 61 8 1134 1135
90. Pillon B., Blin J., Vidailhet M., et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology: 1995; 45 8 1477 1483
91. Litvan I., Cummings J. L., Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry: 1998; 65 5 717 721
92. Cummings J. L. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology: 1997; 48 5 06 S10 S16
93. Cummings J. L., Litvan I. Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol: 2000; 82 147 152
94. Cummings J. L., Diaz C., Levy M., Binetti G., Litvan I. Neuropsychiatric Syndromes in Neurodegenerative Disease: Frequency and Signficance. Semin Clin Neuropsychiatry: 1996; 1 4 241 247
95. Santamaría J., Tolosa E., Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology: 1986; 36 8 1130 1133
96. Blin J., Vidailhet M. J., Pillon B., Dubois B., Feve J. R., Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord: 1992; 7 4 348 354
97. Juh R., Pae C. U., Kim T. S., Lee C. U., Choe B., Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett: 2005; 383 1-2 22 27
98. Zhao P., Zhang B., Gao S. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. Parkinsonism Relat Disord: 2012; 18 01 S60 S62
99. Vandenberghe R., Adamczuk K., Van Laere K. The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease. Curr Opin Neurol: 2013; 26 6 646 655
100. Josephs K. A., Whitwell J. L., Dickson D. W., et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging: 2008; 29 2 280 289
101. Gröschel K., Hauser T. K., Luft A., et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage: 2004; 21 2 714 724
102. Tedeschi G., Litvan I., Bonavita S., et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain: 1997; 120 Pt 9 1541 1552
103. Pirker S., Perju-Dumbrava L., Kovacs G. G., Traub-Weidinger T., Asenbaum S., Pirker W. Dopamine D2 receptor SPECT in corticobasal syndrome and autopsy-confirmed corticobasal degeneration. Parkinsonism Relat Disord: 2013; 19 2 222 226
104. Sajjadi S. A., Acosta-Cabronero J., Patterson K., Diaz-de-Grenu L. Z., Williams G. B., Nestor P. J. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases. Brain: 2013; 136 Pt 7 2253 2261
105. Hess C. P., Christine C. W., Apple A. C., Dillon W. P., Aminoff M. J. Changes in the Thalamus in Atypical Parkinsonism Detected Using Shape Analysis and Diffusion Tensor Imaging. AJNR Am J Neuroradiol: 2013
106. van de Wassenberg W. J., van der Hoeven J. H., Leenders K. L., Maurits N. M. 128-channel somatosensory evoked potentials in the differential diagnosis of parkinsonian disorders. Parkinsonism Relat Disord: 2009; 15 8 564 571
107. Bruns M. B., Josephs K. A. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. Int Rev Psychiatry: 2013; 25 2 197 209
108. Urakami K., Mori M., Wada K., et al. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. Neurosci Lett: 1999; 259 2 127 129
109. Mitani K., Furiya Y., Uchihara T., et al. Increased CSF tau protein in corticobasal degeneration. J Neurol: 1998; 245 1 44 46
110. Arai H., Morikawa Y., Higuchi M., et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun: 1997; 236 2 262 264
111. Portelius E., Hansson S. F., Tran A. J., et al. Characterization of tau in cerebrospinal fluid using mass spectrometry. J Proteome Res: 2008; 7 5 2114 2120
112. Schoonenboom N. S., Reesink F. E., Verwey N. A., et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology: 2012; 78 1 47 54
113. Maruyama M., Shimada H., Suhara T., et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron: 2013; 79 6 1094 1108
114. Ludolph A. C., Kassubek J., Landwehrmeyer B. G., et al. Reisensburg Working Group for Tauopathies With Parkinsonism. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol: 2009; 16 3 297 309
115. Wischik C. M., Edwards P. C., Lai R. Y., Roth M., Harrington C. R. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A: 1996; 93 20 11213 11218
116. Pérez M., Hernández F., Lim F., Díaz-Nido J., Avila J. Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J Alzheimers Dis: 2003; 5 4 301 308
117. Brunden K. R., Ballatore C., Crowe A., Smith A. B. III, Lee V. M., Trojanowski J. Q. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol: 2010; 223 2 304 310
118. Yanamandra K., Kfoury N., Jiang H., et al. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron: 2013; 80 2 402 414